Ask AI
MDT BRIDGE
MDT-BRIDGE: Phase II Trial of Neoadjuvant Durvalumab + CT and Subsequent Surgery + Adjuvant Durvalumab or CRT + Consolidation Durvalumab for Resectable Stage IIB-IIIB NSCLC

Released: October 24, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: October 24, 2025